Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Published : May-2019

No. of Pages : 627

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Injectable Drug Delivery Devices Overview
3 Products under Development
3.1 Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Injectable Drug Delivery Devices - Pipeline Products by Segment
3.3 Injectable Drug Delivery Devices - Pipeline Products by Territory
3.4 Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Injectable Drug Delivery Devices - Ongoing Clinical Trials
4 Injectable Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Injectable Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
5 Injectable Drug Delivery Devices Companies and Product Overview
5.1 AdrenaCard, Inc. Company Overview
5.2 Allergan Plc Company Overview
5.3 Alsensa ApS Company Overview
5.4 Antares Pharma Inc Company Overview
5.5 Aquavit Pharmaceuticals Inc Company Overview
5.6 Artemes Technologies, Inc. Company Overview
5.7 Ascendis Pharma A/S Company Overview
5.8 Ascil Proyectos SL Company Overview
5.9 ASIS Corp Company Overview
5.10 AzureBio SL Company Overview
5.11 BCWorld Pharm Co Ltd Company Overview
5.12 Becton Dickinson and Co Company Overview
5.13 Bespak Europe Ltd Company Overview
5.14 BioCorRx Inc Company Overview
5.15 BioMarin Pharmaceutical Inc Company Overview
5.16 BioRestorative Therapies Inc Company Overview
5.17 Bioxis Pharmaceuticals Company Overview
5.18 Brigham and Women's Hospital Company Overview
5.19 Burke Pharmaceuticals LLC Company Overview
5.20 Callisyn Biomedical Inc Company Overview
5.21 Cambridge Consultants Ltd Company Overview
5.22 Camurus AB Company Overview
5.23 Case Western Reserve University Company Overview
5.24 Catalent Inc Company Overview
5.25 Cincinnati Children's Hospital Medical Center Company Overview
5.26 Clearside BioMedical Inc Company Overview
5.27 DALI Medical Devices Ltd. Company Overview
5.28 DelSite, Inc. (Inactive) Company Overview
5.29 Drexel University Company Overview
5.30 Elcam Medical Company Overview
5.31 EmboMedics Inc Company Overview
5.32 Emergent BioSolutions Inc Company Overview
5.33 EP Global Communications Inc (Inactive) Company Overview
5.34 EP Technologies LLC Company Overview
5.35 Eveon SAS Company Overview
5.36 EyePoint Pharmaceuticals Inc Company Overview
5.37 FHC Inc Company Overview
5.38 GeneSYS-ID Inc Company Overview
5.39 Ghent University Company Overview
5.40 Globe Medical Tech Inc (Inactive) Company Overview
5.41 Inovio Pharmaceuticals Inc Company Overview
5.42 InVivo Therapeutics Corp Company Overview
5.43 Ipsen SA Company Overview
5.44 JCR Pharmaceuticals Co Ltd Company Overview
5.45 Lohmann Therapie-Systeme AG Company Overview
5.46 LyoGo Company Overview
5.47 Mallinckrodt Plc Company Overview
5.48 Mertiva AB Company Overview
5.49 Midas Pharma GmbH Company Overview
5.50 Milestone Scientific Inc Company Overview
5.51 NanoPass Technologies Ltd Company Overview
5.52 Novosanis NV Company Overview
5.53 Osteo Pharma BV Company Overview
5.54 Oval Medical Technologies Ltd Company Overview
5.55 Particle Therapeutics Ltd Company Overview
5.56 Pfizer Inc Company Overview
5.57 Portal Instruments Inc Company Overview
5.58 Queen Elizabeth Hospital Company Overview
5.59 QuiO Technologies LLC Company Overview
5.60 RepliCel Life Sciences Inc Company Overview
5.61 Rescitech Vision Pvt Ltd Company Overview
5.62 RetinaPharma Technologies Inc Company Overview
5.63 Revance Therapeutics Inc Company Overview
5.64 Roche Diagnostics International Ltd Company Overview
5.65 Sapporo Medical University School of Medicine Company Overview
5.66 Takeda Pharmaceutical Co Ltd Company Overview
5.67 TCB medical devices Company Overview
5.68 Terumo Corp Company Overview
5.69 Teva Pharmaceutical Industries Ltd Company Overview
5.70 TheraKine Inc (Inactive) Company Overview
5.71 Twin Star Medical Inc Company Overview
5.72 Unilife Corporation Company Overview
5.73 University of Calgary Company Overview
5.74 University of California San Diego Company Overview
5.75 University of California San Francisco Company Overview
5.76 University of Delaware Company Overview
5.77 University of Dundee Company Overview
5.78 University of Florida Company Overview
5.79 University of Saskatchewan Company Overview
5.80 University of Texas at Austin Company Overview
5.81 Vanderbilt University Company Overview
5.82 West Pharmaceutical Services Inc Company Overview
5.83 Windgap Medical Inc Company Overview
5.84 XERIS Pharmaceuticals Inc Company Overview
5.85 Ypsomed Holding AG Company Overview
6 Injectable Drug Delivery Devices - Recent Developments
6.1 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018
6.2 Apr 24, 2019: Alkermes appoints Industry Veteran C. Todd Nichols as Senior Vice President of Sales and Marketing
6.3 Apr 23, 2019: Catalent invests $14 million at Its Eberbach, Germany Softgel facility
6.4 Apr 18, 2019: Clearside Biomedical announces multiple presentations on its Suprachoroidal Space injection platform at upcoming medical meetings
6.5 Apr 15, 2019: Dr. Reddy's Laboratories received the Establishment Inspection Report (BIR) from US FDA for its Manufacturing Plant -3 at Bachupally, Hyderabad
6.6 Apr 11, 2019: Milestone Scientific showcases the CompuFlo Epidural Instrument at ASRA 2019
6.7 Apr 11, 2019: Catalent Celebrates opening of second Shanghai facility to optimize global and local clinical supply solutions for China
6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
6.9 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors
6.10 Apr 08, 2019: Milestone Scientific appoints fund manager and finance veteran Neal Goldman to Board of Directors
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
Table 2: Injectable Drug Delivery Devices - Pipeline Products by Segment
Table 3: Injectable Drug Delivery Devices - Pipeline Products by Territory
Table 4: Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
Table 5: Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Table 6: Injectable Drug Delivery Devices - Ongoing Clinical Trials
Table 7: Injectable Drug Delivery Devices Companies - Pipeline Products by Stage of Development
Table 8: Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
Table 9: AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Adrenacard Auto-Injector - Product Status
Table 11: Adrenacard Auto-Injector - Product Description
Table 12: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: NOVADUR Intravitreal Implant - Product Status
Table 14: NOVADUR Intravitreal Implant - Product Description
Table 15: Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
Table 16: SQJCT - Product Status
Table 17: SQJCT - Product Description
Table 18: Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Methotrexate Auto Injector - Ectopic Pregnancy - Product Status
Table 20: Methotrexate Auto Injector - Ectopic Pregnancy - Product Description
Table 21: Vibex QS M - Product Status
Table 22: Vibex QS M - Product Description
Table 23: Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: PITO-001 - Product Status
Table 25: PITO-001 - Product Description
Table 26: Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Artemes Magnetic Injection System - Product Status
Table 28: Artemes Magnetic Injection System - Product Description
Table 29: Ascendis Pharma A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 30: TransCon hGH Auto-Injector - Product Status
Table 31: TransCon hGH Auto-Injector - Product Description
Table 32: Ascendis Pharma A/S - Ongoing Clinical Trials Overview
Table 33: TransCon hGH Auto-Injector - A Multicenter, Phase III, Long-term, Open-label Trial Investigating Safety and Efficacy of TransCon hGH Administered Once-weekly in Children with Growth Hormone Deficiency (GHD) Who Have Completed a Prior TransCon hGH Clinical Trial: enliGHten
Table 34: TransCon hGH Auto-Injector - fliGHT: A Multicenter, Phase 3, Open-label, 26-week Trial Investigating the Safety, Tolerability and Efficacy of Transcon Hgh Administered Once Weekly in Children With GHD
Table 35: Ascil Proyectos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 36: ASTECH - Product Status
Table 37: ASTECH - Product Description
Table 38: Combo Connector - Dual Chamber Device - Product Status
Table 39: Combo Connector - Dual Chamber Device - Product Description
Table 40: Combo Connector - Microdosing Device - Product Status
Table 41: Combo Connector - Microdosing Device - Product Description
Table 42: Combo Connector - Prefilled Device - Product Status
Table 43: Combo Connector - Prefilled Device - Product Description
Table 44: Combo-Connector Device - Product Status
Table 45: Combo-Connector Device - Product Description
Table 46: ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Automatic Subdermal Injection System - Product Status
Table 48: Automatic Subdermal Injection System - Product Description
Table 49: ASIS Corp - Ongoing Clinical Trials Overview
Table 50: Automatic Subdermal Injection System - ASIS for Botox in Chronic Migraine
Table 51: Automatic Subdermal Injection System - ASIS for Botox in Upper Limb Spasticity
Table 52: Automatic Subdermal Injection System - ASIS for Enbrel in Plaque Psoriasis
Table 53: AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Injectable Needle - Product Status
Table 55: Injectable Needle - Product Description
Table 56: BCWorld Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 57: LASTINA Microsphere - Product Status
Table 58: LASTINA Microsphere - Product Description
Table 59: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 60: BD Intevia Disposable Autoinjector - Product Status
Table 61: BD Intevia Disposable Autoinjector - Product Description
Table 62: BD Libertas Wearable Injector - Product Status
Table 63: BD Libertas Wearable Injector - Product Description
Table 64: BD Neopak XSi Glass Pre-Fillable Syringe - Product Status
Table 65: BD Neopak XSi Glass Pre-Fillable Syringe - Product Description

1.2 List of Figures
Figure 1: Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
Figure 2: Injectable Drug Delivery Devices - Pipeline Products by Segment
Figure 3: Injectable Drug Delivery Devices - Pipeline Products by Territory
Figure 4: Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
Figure 5: Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Injectable Drug Delivery Devices - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027